A Cohort Study on the Safety and Efficacy of Warfarin and Rivaroxaban in Anticoagulant Therapy in Patients with Atrial Fibrillation Study

OBJECTIVE: To observe the safety and efficacy of warfarin and rivaroxaban in anticoagulation therapy in patients with atrial fibrillation (AF). METHODS: A total of 96 patients with AF treated in our hospital from June 2019 to February 2021 were enrolled in this study. According to the different mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Yao, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283039/
https://www.ncbi.nlm.nih.gov/pubmed/35845939
http://dx.doi.org/10.1155/2022/4611383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283039/
https://www.ncbi.nlm.nih.gov/pubmed/35845939
http://dx.doi.org/10.1155/2022/4611383

Ejemplares similares